دورية أكاديمية

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

التفاصيل البيبلوغرافية
العنوان: Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
المؤلفون: Beckers, D., THOMAS, M., Jamart, J., FRANCOIS, I., MAES, M., LEBRETHON, Marie-Christine, De Waele, K., Tenoutasse, S., De Schepper, J.
المصدر: European Journal of Endocrinology, 162 (3), 483-90 (2010)
بيانات النشر: BioScientifica Ltd
سنة النشر: 2010
المجموعة: University of Liège: ORBi (Open Repository and Bibliography)
مصطلحات موضوعية: Adolescent, Adult, Age Factors, Belgium, Body Height/drug effects/radiation effects, Brain Neoplasms/radiotherapy, Chi-Square Distribution, Child, Preschool, Databases, Factual, Female, Human Growth Hormone/deficiency/therapeutic use, Humans, Hypopituitarism/etiology, Infant, Male, Patient Selection, Pituitary Gland/physiopathology/radiation effects, Radiotherapy/adverse effects, Regression Analysis, Retrospective Studies, Sex Factors, Statistics, Nonparametric, Survivors, Human health sciences, Endocrinology, metabolism & nutrition, Sciences de la santé humaine
الوصف: peer reviewed ; OBJECTIVES: The treatment of brain tumors in childhood is frequently complicated by growth retardation with a high proportion of irradiation (Irr)-induced GH deficiency (GHD) resulting in reduced adult final height (AFH) even after GH therapy (GHT). In order to optimize future GHT protocols, more information on the factors influencing the growth response to GH in these children is needed. This retrospective study evaluated AFH and influencing auxological and treatment factors of a standardized daily biosynthetic GHT in childhood survivors of brain tumors with documented GHD after brain Irr. DESIGN AND METHODS: From the Belgian GH Registry, 57 children survivors of a brain tumor outside the hypothalamo-pituitary area with available AFH were stratified into two groups depending on cranial (C-Irr; n=25) or craniospinal (CS-Irr; n=32) Irr. RESULTS: In the C-Irr patients, results showed an AFH of -0.8 (-2.5, 1.4) SDS (median (range)) and in the CS-Irr patients, results showed a significantly (P<0.001) lower AFH of -1.8 (-4.2, 0.0) SDS. AFH SDS corrected for mid-parental height (MPH) in the C-Irr group was -0.5 (-2.2, 0.9) and -1.5 (-3.6, 0.0) SDS in the CS-Irr group. AFH was positively correlated with age at end of tumor therapy, height SDS at start GHT, height gain SDS first year GHT, and negatively correlated with CS-Irr. CONCLUSIONS: GHT failed to restore adult height to MPH in nearly half of Irr-induced GHD patients for brain tumor, especially those receiving CS-Irr, irradiated at a younger age or shorter at start GHT.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0804-4643
1479-683X
العلاقة: urn:issn:0804-4643; urn:issn:1479-683X; https://orbi.uliege.be/handle/2268/109521Test; info:hdl:2268/109521; https://orbi.uliege.be/bitstream/2268/109521/1/Beckers%20D%20et%20al%20%28adult%20final%20height%20after%20GH.%29%20Eur%20J%20Endocrinol%202010.pdfTest; scopus-id:2-s2.0-77149134944; info:pmid:19969557
DOI: 10.1530/EJE-09-0690
الإتاحة: https://doi.org/10.1530/EJE-09-0690Test
https://orbi.uliege.be/handle/2268/109521Test
https://orbi.uliege.be/bitstream/2268/109521/1/Beckers%20D%20et%20al%20%28adult%20final%20height%20after%20GH.%29%20Eur%20J%20Endocrinol%202010.pdfTest
حقوق: open access ; http://purl.org/coar/access_right/c_abf2Test ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.5523DA57
قاعدة البيانات: BASE
الوصف
تدمد:08044643
1479683X
DOI:10.1530/EJE-09-0690